Introduction
The transcription factor p53, acts at a pivotal point of multiple stress-response pathways, and as such its activity in proliferating cells must be tightly regulated in order to prevent activation of a cell-cycle arrest or apoptotic response. The primary pathway whereby p53 function is restricted in unstressed cells is via interaction with the Hdm2 oncoprotein (Mdm2 in mouse) [1] . Hdm2 suppresses the transcriptional activation function of p53, and also promotes its nuclear export and proteosomedependent destruction [2] . In absence of Hdm2 function, normal fibroblast cells induce expression of the cdk inhibitor, p21 WAF1 , and undergo a p53-dependent cell -3 -cycle arrest [3] , whereas in other cell-types, spontaneous apoptosis may occur [4] [5] [6] .
Hdm2 / Mdm2 is itself a transcriptional target of p53, as the gene has a promoter, P2, which contains p53 binding sites [7, 8] and, in in vitro cultured mouse embryo fibroblasts the levels of the mdm2-P2 mRNA transcript is highly dependent upon p53 [9] . A second promoter, P1, is constitutively active, though the mdm2 / hdm2-P1 mRNA transcript is poorly translated [10] .
Levels of Hdm2 / Mdm2 protein are positively regulated by growth factor signalling pathways that promote cell proliferation and survival [11, 12] . Several distinct mechanisms underlying this regulation have been demonstrated: Mosner et al [11] showed that the increased Mdm2 occurred in the absence of any increase in total mdm2 mRNA on Northern blots, however expression of the mdm2 gene was subsequently shown to be induced with immediate early kinetics in response to signalling from chimeric platelet-derived growth factor β receptors [13] . Experimental activation of one of the major growth factor receptor tyrosine kinase-induced pathways, the Ras-Raf-MEK-ERK kinase cascade, induces mdm2 P2-transcription through activation of AP1 and ETS transcription factor binding to sites in the murine P2-promoter [14] . We have previously shown that this pathway is at least partially conserved in human cells [15, 16] , and Ras-Raf-MEK-ERK signalling also selectively promotes the export of hdm2 mRNA from the nucleus to sites of translation in the cytoplasm [16] . Ras-Raf-MEK-ERK signalling is also known to regulate Hdm2 function through the increased transcription of the Hdm2-binding protein p14 ARF [17] .
Finally, growth factor induced activation of phosphatidylinositol-3 kinase (PI 3 kinase)
-Akt/PKB kinase signalling results in phosphorylation of Hdm2 / Mdm2, which
Regulation of Hdm2 expression -4 -increases the levels of the protein by reducing its rate of proteosome-dependent degradation [18] [19] [20] .
Given that these mechanisms have been the subject of independent studies, it is difficult to determine their relative contribution to the levels in Hdm2 protein expression in any given situation. To address this, we have taken a well defined experimental model, induction of Hdm2 expression immediately following serum restimulation of non-transformed human fibroblasts, and undertaken an investigation of the mechanisms regulating Hdm2 protein levels in these cells.
Methods

Cell culture, reagents, and cell cycle analysis
MRC-5 hTERT cells [21] were cultured in Dulbecco's modified Eagle's medium 
mRNA and protein quantification.
Regulation of Hdm2 expression -5 -Western blotting was performed as described previously [16] using antibodies to Hdm2 (2A9 or 2A10 [22] , (2A9 was used unless indicated otherwise)), p53 (DO-1, Serotec), p21 WAF-1 (Clone SX118, Pharmingen), β-actin (Sigma), AKT, phospho-Ser-473 Akt, ERK1/ERK2 and phospho-Thr202r/Tyr204 ERK1/ERK2 (all from Cell Signalling Technology). mRNA analysis, cell fractionation, polyribosome purification, RNA extraction, and validation of the fractionation by semi-quantitative PCR for small cytoplasmic RNA Y4, was performed as described previously [16] .
cDNA synthesis and Taqman quantitative PCR (qPCR) for hdm2-P1, hdm2-P2, hdm2-CDS and gapdh was performed using previously described primers and probes [16] . hdm2 qPCR assays were performed in duplicate, and mean values normalised to gapdh levels. n values represent the number of individually treated sets of cells analysed.
Results
Hdm2 is required for cell-cycle progression in hTERT-immortalised normal human fibroblasts.
MRC-5 hTERT is an immortal cell line that has been derived by retroviral transduction of MRC-5, a well characterised human fibroblast strain, with a vector expressing the hTERT component of telomerase [21] . Previous work has shown that serum stimulation of growth arrested MRC-5 cells induces a rapid, and robust accumulation of Hdm2 protein [19] . We therefore first established whether MRC- 
Effects of serum-stimulation on hdm2 mRNA synthesis, nuclear export and translation.
We next investigated whether the elevation of Hdm2 protein levels following serum stimulation involves a selective increase in hdm2-mRNA expression, using previously validated reverse transcription -qPCR assays which are specific to each hdm2 transcript [16] . 1 h following serum stimulation there was no significant increase in Regulation of Hdm2 expression -7 -either hdm2-P1 or hdm2-P2 transcript levels in the cells, compared to the gapdh housekeeping mRNA (Fig. 2Ai) . A qPCR assay directed towards the hdm2 coding sequence (CDS) also showed no change. This contrasted to when p53-dependent transcription in the cells was activated by Nutlin-3 ( Fig. 2Aii) , which caused an 11.7
fold increase in hdm2 P2-transcript levels, and a corresponding 5.2 fold increase in total hdm2 CDS mRNA.
We therefore performed sub-cellular fractionation analysis [16] to determine whether hdm2 mRNA is regulated at the post-transcriptional level following serum-stimulation (Fig. 2B ). Within the 1 h timescale examined, there was no significant increase in the levels of hdm2 mRNA transcripts in the cytoplasmic fraction, indicating that serum stimulation does not lead to a selective enhancement of nuclear export of hdm2 mRNA. Furthermore, when cytoplasmic extracts were subjected to sucrose density centrifugation, there was no serum-induced increase in hdm2 transcripts in the high molecular weight-polyribosome associated fraction, indicating that rates of hdm2 translation are not selectively increased.
Role of PI 3 kinase -Akt-dependent Hdm2 protein stabilisation
Fig . 3A shows that when proteosome-dependent degradation of Hdm2 is inhibited using MG132, Hdm2 protein accumulates as least as rapidly as is does following serum stimulation. Therefore Hdm2 protein is being actively synthesised in serum starved cells, and serum-induced signalling pathways could theoretically cause the observed increase in Hdm2 protein solely by reducing the rates of its degradation. Hdm2 is degraded more rapidly than in serum starved cells.
MEK activity is required for optimal Hdm2 protein synthesis
The previous experiments do not exclude a role for Ras-Raf-MEK-ERK signalling in optimal growth factor-induced Hdm2 expression, and therefore we investigated the role of this pathway. We found that, when the pharmacological MEK inhibitor U0126
is added at the time of serum re-stimulation, ERK activation is blocked and a modest, Regulation of Hdm2 expression -9 -but reproducible, decrease in Hdm2 protein levels is observed (Fig. 4A) . U0126 also causes a small reduction in the Hdm2 protein levels induced by MG132, indicating a decrease in the rate of protein synthesis following MEK inhibition. This reduction in Hdm2 synthesis did not occur due to any specific effects on hdm2 mRNA synthesis or translation, as U0126 did not cause any decrease in hdm2 mRNA associated with polyribosomes relative to gapdh mRNA (Fig. 4B) . However, when the amounts of RNA yielded from the different fractions were analysed, we observed a reduction in the proportion of the total cytoplasmic RNA that was associated with polyribosomes from 42% in serum re-stimulated cells to 24% with U0126 treatment. This represents a 42% decrease in global translation rates following MEK inhibition, and would account for the U0126-induced reduction in Hdm2 protein levels compared to the majority of other, more stable, cellular proteins.
Discussion
Along with p53, Hdm2 lies at a point of integration of a huge range of both intra-and extra-cellular stimuli, the fine balance of the activities of these two proteins playing a key role in cell proliferation and survival [1] . Hdm2 itself can be regulated at multiple points, both pre-and post-translational, even in response to a single type of stimulus
and it is often difficult to establish, in any given situation, which mechanisms are primarily responsible for any observed changes in cellular Hdm2 activity. Here we have shown that, when phenotypically normal human fibroblast cells are stimulated to proliferate by serum growth factors, the rapid increase in Hdm2 protein levels is primarily dependent upon activation of the PI 3 kinase -Akt/PKB signalling pathway, and resultant reduced rates of proteosome-dependent degradation of the Hdm2
Regulation of Hdm2 expression -10 -protein, which is known to involve the direct phosphorylation of Hdm2 by Akt/PKB [18] [19] [20] .
A second major growth factor-induced kinase cascade, Ras-Raf-MEK-ERK is, as has previously been shown in different experimental systems by a number of groups including our own [13, 14, 16] , also required for optimal rates of Hdm2 synthesis in these cells. However, this is not due to any selective regulation of hdm2 mRNA expression or translation, but rather reflects the known requirement for Ras-Raf-MEK-ERK signalling for the global increase in mRNA translation and protein synthesis in response to serum growth factors [23, 24] . It is interesting to consider why the previously described mechanisms of specific MEK-dependent regulation of Hdm2 synthesis are not observed in this system. We have shown previously that incubation of breast cancer epithelial cells with U0126 for 7-24 h results in the selective inhibition of nuclear export of hdm2 mRNA [16] , however serum stimulation of fibroblasts has no specific effect on hdm2 mRNA export. Potentially therefore, hdm2 regulation at this level occurs in some cell types, and not others, or alternatively the effect may only be observed following prolonged inhibition of MEK activity. Other studies have shown murine mdm2 to be induced by growth factors receptors and RasRaf-MEK-ERK signalling, through immediate early type transcriptional activation of the P2 promoter [13, 14] , Here we have shown that this does not occur following serum stimulation of human fibroblasts. Whilst we have previously confirmed that human Hdm2-P2 transcription expression is positively influenced by MEK activity in cancer cells [16] , we have noted differences in the transcription factor binding elements in the human and murine P2-promoters which could result in the human promoter being less responsive to this pathway [15] . Alternatively, it may be relevant Regulation of Hdm2 expression -11 -that previous reports [13, 14] only directly demonstrated MEK-dependent regulation of P2 transcription when components of the signalling pathway were either artificially over-expressed, or contained constitutive activating mutations, and therefore, overstimulation of the growth factor receptor-Ras-Raf-MEK-ERK pathway may be required for Hdm2 P2 promoter activation to occur.
In the broader perspective, Hdm2 over-expression is associated with a wide number of malignancies and Hdm2 is a target for a new class of small molecules with potential a cancer therapeutics [6] . This study on the normal pathways of Hdm2 regulation highlights some of the multiplicity of mechanisms whereby dysregulated intracellular signalling pathways might result in Hdm2 over-expression in tumours. before 100 µg/ml cycloheximide (CHX) was added to the medium to block new protein synthesis. Cells were lysed at the time points indicated after cyclohexamide addition. 
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